Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 1.03 | N/A |
| PEG Ratio (TTM) | -0.03 | N/A |
| P/S Ratio (TTM) | 0.10 | N/A |
| P/B Ratio (TTM) | 0.06 | N/A |
| P/FCF Ratio (TTM) | 1.06 | N/A |
| Price to 5YR AVG Earnings Ratio | 0.56 | N/A |
| Price to 5YR AVG FCF Ratio | -1.76 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.18% | N/A |
| ROE (TTM) | 6.27% | N/A |
| Net Profit Margin (TTM) | 9.85% | N/A |
| ROIC 5YR AVG | 20.26% | N/A |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -19.76% | 6.40% | 6.21% |
| Revenue | -14.14% | 11.28% | 5.43% |
| Net Income | -16.08% | 11.04% | 9.83% |
| Cash Flow | 21.04% | -55.01% | -3,340.60% |
Health (56%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.78 | N/A |
| Quick Ratio (TTM) | 4.74 | N/A |
| D/E Ratio (TTM) | 0.08 | N/A |
| Interest Coverage (TTM) | 88.72 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 2.58 | N/A |
| LTL to 5YR AVG FCF | 0.00 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.98% | N/A |